Investor FAQs

Where is Aligos Therapeutic’s corporate headquarters?
Aligos Therapeutics is headquartered at 1 Corporate Drive, 2nd floor, South San Francisco, CA 94080.
Where is the company incorporated?
Aligos Therapeutics is incorporated in the State of Delaware.
When did Aligos Therapeutics go public?
Aligos Therapeutics’s stock began publicly traded on October 16, 2020.
What is Aligos Therapeutics’s fiscal year?
December 31st.
How is Aligos Therapeutics stock traded?
Aligos Therapeutics is traded on the NASDAQ Global Select Market under the ticker symbol ALGS.
Who is Aligos Therapeutics transfer agent?
To contact CSTT directly with inquiries regarding your stock holdings, please visit CSTT's web page http://www.continentalstock.com for information on requirements, FAQ and useful shareholder documents.

By Phone:
Customer Service - between the hours of 8:30 am. and 5:30 pm. EST, Monday through Friday: 800- 509-5586

By E-Mail:
You may also contact us via e-mail at: cstmail@continentalstock.com

By Mail:
Written correspondence may be directed to:
Continental Stock Transfer & Trust Company
Attn: Customer Service
1 State Street, 30th Floor
New York, NY 10004-1561
Who is Aligos Therapeutics auditor?
Ernst & Young LLP
275 Shoreline Drive
Suite 600
Redwood City, CA 94065
Who is Aligos Therapeutics legal counsel?
​​​​​​Latham & Watkins, LLP
505 Montgomery Street, Suite 2000
San Francisco, CA 94111
Where can I get the latest corporate news releases?
Corporate News on the Investor website.
How can I view documents Aligos Therapeutics has filed with the Securities & Exchange Commission (SEC), including Forms 10-K and 10-Q?
By visiting www.sec.gov.